Jiangsu Hengrui Medicine
600276.SS
#509
Rank
โ‚น3.514 T
Marketcap
โ‚น550.50
Share price
0.02%
Change (1 day)
8.93%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): โ‚น7.46

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is โ‚น7.94. In 2022 the company made an earnings per share (EPS) of โ‚น7.91 a decrease over its 2021 EPS that were of โ‚น9.55.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น7.46-5.76%
2022โ‚น7.91-17.1%
2021โ‚น9.55-24.44%
2020โ‚น12.6320.3%
2019โ‚น10.5025.58%
2018โ‚น8.3627.55%
2017โ‚น6.5621.64%
2016โ‚น5.3913.57%
2015โ‚น4.7539.86%
2014โ‚น3.3921.33%
2013โ‚น2.8017.7%
2012โ‚น2.3825.56%
2011โ‚น1.8926.22%
2010โ‚น1.5010.3%
2009โ‚น1.3657.92%
2008โ‚น0.8611.06%
2007โ‚น0.7885.81%
2006โ‚น0.4287.94%
2005โ‚น0.2233.97%
2004โ‚น0.1729.78%
2003โ‚น0.1319.78%
2002โ‚น0.11